BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7526777)

  • 1. Molecular mimicry between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome.
    Yuki N; Taki T; Takahashi M; Saito K; Yoshino H; Tai T; Handa S; Miyatake T
    Ann Neurol; 1994 Nov; 36(5):791-3. PubMed ID: 7526777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pathogenesis of Guillain-Barré syndrome and Fisher's syndrome: molecular mimicry between antecedent infectious agents and components of nerve tissues].
    Yuki N
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1373-5. PubMed ID: 8752400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome.
    Jacobs BC; Endtz H; van der Meché FG; Hazenberg MP; Achtereekte HA; van Doorn PA
    Ann Neurol; 1995 Feb; 37(2):260-4. PubMed ID: 7531419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
    Yuki N
    Rinsho Byori; 1999 Aug; 47(8):713-8. PubMed ID: 10511801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.
    Koga M; Gilbert M; Li J; Koike S; Takahashi M; Furukawa K; Hirata K; Yuki N
    Neurology; 2005 May; 64(9):1605-11. PubMed ID: 15883324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Campylobacter gene polymorphism as a determinant of clinical features of Guillain-Barré syndrome.
    Koga M; Takahashi M; Masuda M; Hirata K; Yuki N
    Neurology; 2005 Nov; 65(9):1376-81. PubMed ID: 16162859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
    Yuki N
    J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of Guillain-Barré and Miller Fisher syndromes subsequent to Campylobacter jejuni enteritis.
    Yuki N
    Jpn J Infect Dis; 1999 Jun; 52(3):99-105. PubMed ID: 10507987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fisher syndrome associated with IgG anti-GQ1b antibody following infection by a specific serotype of Campylobacter jejuni.
    Ohtsuka K; Nakamura Y; Hashimoto M; Tagawa Y; Takahashi M; Saito K; Yuki N
    Ophthalmology; 1998 Jul; 105(7):1281-5. PubMed ID: 9663234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-ganglioside antibody and neuropathy: review of our research.
    Yuki N
    J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
    Ang CW; De Klerk MA; Endtz HP; Jacobs BC; Laman JD; van der Meché FG; van Doorn PA
    Infect Immun; 2001 Apr; 69(4):2462-9. PubMed ID: 11254608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fisher's syndrome following Campylobacter jejuni enteritis--a case report and review of the literature].
    Ichikawa H; Sugita K; Fukui T; Saito K; Yuki N
    Rinsho Shinkeigaku; 1995 Apr; 35(4):391-5. PubMed ID: 7614765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].
    Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N
    Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Campylobacter jejuni and autoimmune-mediated neurologic diseases: pathogenesis of Guillain-Barré syndrome and Fisher's syndrome].
    Yuki N
    Nihon Saikingaku Zasshi; 1995 Oct; 50(4):991-1003. PubMed ID: 8544349
    [No Abstract]   [Full Text] [Related]  

  • 15. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome.
    Yuki N
    Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guillain-Barré syndrome and Fisher's syndrome following Campylobacter jejuni infection.
    Yuki N; Miyatake T
    Ann N Y Acad Sci; 1998 Jun; 845():330-40. PubMed ID: 9668366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
    Nachamkin I; Ung H; Moran AP; Yoo D; Prendergast MM; Nicholson MA; Sheikh K; Ho T; Asbury AK; McKhann GM; Griffin JW
    J Infect Dis; 1999 May; 179(5):1183-9. PubMed ID: 10191221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipopolysaccharides in the development of the Guillain-Barré syndrome and Miller Fisher syndrome forms of acute inflammatory peripheral neuropathies.
    Prendergast MM; Moran AP
    J Endotoxin Res; 2000; 6(5):341-59. PubMed ID: 11521055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Campylobacter jejuni serotype with antiganglioside antibody in Guillain-Barré syndrome and Fisher's syndrome.
    Yuki N; Takahashi M; Tagawa Y; Kashiwase K; Tadokoro K; Saito K
    Ann Neurol; 1997 Jul; 42(1):28-33. PubMed ID: 9225682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies induced by ganglioside-mimicking Campylobacter jejuni lipooligosaccharides recognise epitopes at the nodes of Ranvier.
    Moran AP; Annuk H; Prendergast MM
    J Neuroimmunol; 2005 Aug; 165(1-2):179-85. PubMed ID: 15993494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.